98%
921
2 minutes
20
Typical atrial flutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heart failure, and death. Typical AFL occurs in patients with atrial remodeling and shares risk factors with atrial fibrillation. It is also common in patients with a history of prior heart surgery or catheter ablation. It is characterized by a recognizable ECG pattern that is highly predictive of CTI-dependent re-entry in patients without iatrogenic atrial scars. Typical AFL is difficult to manage medically due to poor efficacy of rate-controlling and antiarrhythmic drugs. Catheter ablation has been established in randomized trials to be superior to medical management in terms of safety, efficacy, and clinical outcomes including hospitalization and quality of life. Catheter ablation aims at achieving bidirectional conduction block across the CTI, which can be efficiently assessed by well-established techniques such as differential pacing. Long-term ablation success requires creating a stable transmural and continuous lesion, which can be optimized by systematic assessment of ablation parameters and lesion contiguity. The present review discusses the epidemiology, mechanisms, ECG characteristics, medical management, and catheter ablation of typical AFL.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jce.16542 | DOI Listing |
Heart Rhythm
September 2025
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China. Electronic address:
Background: The effectiveness of ethanol infusion of the vein of Marshall (EIVOM) for persistent atrial fibrillation (AF) in patients with mitral valve replacement (MVR) remains to be determined.
Objectives: This study investigated the effectiveness and safety of EIVOM in catheter ablation of persistent AF in patients with MVR.
Methods: This is a retrospective case-control study.
J Interv Card Electrophysiol
September 2025
Electrophysiology Section, Cardiovascular Division, Cleveland Clinic, Cleveland, OH, USA.
Background: Catheter ablation of scar-related interatrial septal atrial tachycardias (IAS-ATs) is challenging and can be refractory to conventional unipolar radiofrequency catheter ablation (RFCA).
Aim: This multicenter study investigated the safety and efficacy of bipolar radiofrequency catheter ablation (Bi-RFCA) in patients with IAS-AT refractory to conventional unipolar RFCA.
Methods: Consecutive patients with scar-related IAS-AT refractory to conventional unipolar RFA across three electrophysiological centers were included in the study.
Heart Lung Circ
September 2025
Cardiology Department, Westmead Hospital, Sydney, NSW, Australia; Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia. Electronic address:
Background: Catheter ablations are increasingly performed with zero or minimal fluoroscopy, enabled by ultrasound imaging and electro-anatomical mapping. Pulsed field ablation (PFA) using Farawave has been dependent on fluoroscopic assessment of catheter conformation and contact. We aimed to demonstrate the feasibility of a PFA workflow for pulmonary vein isolation (PVI) and extrapulmonary ablation.
View Article and Find Full Text PDFBMJ Open
September 2025
Department of Nursing, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Introduction: Atrial fibrillation (AF) is the most common cardiac arrhythmia, significantly affecting patients' quality of life (QoL) and increasing the risk of complications such as heart failure, stroke and dementia. In addition to the physical burden, psychological distress, including depression and anxiety, is prevalent among patients with AF and can exacerbate clinical symptoms and worsen overall well-being. While radiofrequency ablation (RFA) is widely used for rhythm control in AF, its long-term effects on both physical and psychological outcomes, including symptom severity, anxiety, depression and QoL, remain underexplored.
View Article and Find Full Text PDFIndian Heart J
September 2025
Brawijaya Cardiovascular Research Center, Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia. Electronic address:
Background: Atrial fibrillation (AF), affects around 2% of the global population and is projected to rise over the next 50 years. Catheter ablation (CA) is the primary treatment for symptomatic AF resistant to drug therapy. Despite its widespread use, CA has a failure rate of 20% to 50%, often requiring repeat procedures, due to significant long-term recurrence rates.
View Article and Find Full Text PDF